AstraZeneca (NASDAQ:AZN), a global pharmaceutical firm, has announced a C$820 million (US$570 million) investment in Canada, which will result in the creation of over 700 high-skilled jobs across ...

AstraZeneca will expand the its global R&D hub in Mississauga. This $820 million investment underscores Ontario’s growing prominence in the life sciences sector and will create more than 700 ...

AstraZeneca’s investments in Canada since 2023 now exceed $0.9bn, creating a total of 1,200 new high-skilled jobs. In 2024, ...

AstraZeneca will invest 820 million Canadian dollars, equivalent to $570.3 million, to facilitate a move to a larger office in the Toronto metro area. The Anglo-Swedish pharmaceutical giant said ...

AstraZeneca PLC AZN-Q is investing $820-million and creating more than 700 jobs in Ontario’s life sciences industry, stimulating growth within a national research and development sector that has ...

Invest Ontario added that it also provided AstraZeneca with site selection services, market intelligence, and immigration support to streamline the investment process. “This investment is a reflection ...

Invest Ontario is partnering with AstraZeneca (AZN) to expand the company’s global R&D hub in Mississauga. This C$820M investment underscores Ontario’s growing prominence in the life sciences ...

The mega investment is in line with Astrazeneca’s global ambition to achieve 80 billion dollars in Total Revenue and to bring 20 new medicines to patients around the world by 2030.

Cambridge headquartered global pharma company AstraZeneca is investing C$820 million (US$570m) in Canada, creating more than 700 high-skilled jobs across all areas of the business. The investment will ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

"AstraZeneca's COVID vaccine no longer being ... of Medicine published a study co-authored by McMaster University Ontario professor Dr. Theodore Warkentin that said the vaccine "appears to cause ...